LSK Investment
VC Fund
Seoul, South Korea
LSK Investment is a Korean venture capital firm that provides long-term capital and management support to venture enterprises. The firm was founded in 2016 and is based in Seoul, Korea.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries LSK Investment invests in
Stages LSK Investment invests in
Countries LSK Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.6M–$14M
- Series B
- $7.4M–$16M
- Series C
- $3.2M–$46M
Investment Focus
Industry
- Biotechnology 21 (51%)
- Medical 17 (41%)
- Health Care 14 (34%)
- Pharmaceutical 10 (24%)
- Biopharma 9 (22%)
Stage
- Series A 16 (39%)
- Series B 12 (29%)
- Series C 5 (12%)
- Seed 3 (7%)
- Funding Round 2 (5%)
Country
- South Korea 34 (83%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Lee Myung-kwon
Managing Director
|
Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
IMBiologics
|
IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M / Series C / Oct 14, 2025 | |
MBD
|
MBD is a biotechnology company that specializes in 3D cell culture platforms. | $11.9M / Series C / Aug 14, 2025 | |
Trioar
|
Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs. | $16.2M / Series B / Jul 17, 2025 | |
Medi Builder
|
Medi Builder operates as a Medical Accelerator Management Services Organization (MSO), functioning as a non-hospital business agency similar to its subsidiaries, the special-purpose medical companies (SMCs). However, there are significant differences between SMCs and the MSO in terms of capacity for acceleration, growth potential, and exit plans. | $10.3M / Series B / Jun 05, 2025 | |
NeuroXT
|
NeuroXT develops software for precision diagnosis that predicts molecular pathology values. It uses magnetic resonance imaging (MRI) data to assess the effects and adverse reactions of specific drugs, supporting evaluation of patient suitability. The system applies image analysis methods to inform treatment decisions for degenerative braindiseases. | Series A / Mar 10, 2025 | |
Special Touch Nursing Services
|
Special Touch Nursing Services provides in-home nursing care, including health assessments, medication management, and non-medical assistance such as personal care, transportation, and household support. The company also offers licensed case management services to assess needs, coordinate care plans, and advocate on behalf of clients and families.Services are delivered by registered nurses, licensed social workers, nursing assistants, and caregivers to support independence and well-being for seniors and disabled individuals. | $1.3M / Seed / Nov 20, 2024 | |
Avelos Therapeutics
|
Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics. | $12.4M / Series B / May 02, 2024 | |
Refeely
|
Refeely is a refill-focused packaging company that offers B2B packaging solutions using refillable paper cartons for products. The company develops eco-friendly refill products and paper-based packaging system. | $742.8K / Seed / Mar 29, 2024 | |
Surginex
|
Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services. | $6.3M / Series B / Mar 28, 2024 | |
|
Surginex
|
Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services. | $6.3M / Mar 27, 2024 | |
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does LSK Investment invest in?
LSK Investment invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is LSK Investment's check size?
LSK Investment typically joins rounds of $1.6M–$14M at Series A, $7.4M–$16M at Series B and $3.2M–$46M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LSK Investment participates in.
How do I contact LSK Investment?
Public channels for LSK Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LSK Investment?
The team at LSK Investment includes Lee Myung-kwon (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
